Apyx Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1996
Revenue	52.35	44.51	48.52	27.71	28.24	Upgrade
Revenue Growth (YoY)	17.61%	-8.26%	75.08%	-1.86%	70.04%	Upgrade
Cost of Revenue	18.59	15.38	14.92	10.21	9.14	Upgrade
Gross Profit	33.76	29.13	33.6	17.5	19.09	Upgrade
Selling, General & Admin	48.87	48.15	43.73	33.67	36.23	Upgrade
Research & Development	4.84	4.54	4.32	3.92	3.73	Upgrade
Operating Expenses	53.71	52.69	48.05	37.59	39.96	Upgrade
Operating Income	-19.95	-23.56	-14.45	-20.08	-20.87	Upgrade
Interest Expense / Income	2.48	0.02	0.01	0.05	0.01	Upgrade
Other Expense / Income	-1.28	-0.76	0.33	-0.73	-1.04	Upgrade
Pretax Income	-21.15	-22.82	-14.79	-19.4	-19.84	Upgrade
Income Tax	-2.43	0.37	0.38	-7.5	-0.13	Upgrade
Net Income	-18.71	-23.18	-15.17	-11.9	-19.71	Upgrade
Shares Outstanding (Basic)	35	35	34	34	34	Upgrade
Shares Outstanding (Diluted)	35	35	34	34	34	Upgrade
Shares Change	0.31%	0.54%	0.35%	0.42%	-0.86%	Upgrade
EPS (Basic)	-0.54	-0.67	-0.44	-0.35	-0.58	Upgrade
EPS (Diluted)	-0.54	-0.67	-0.44	-0.35	-0.58	Upgrade
Free Cash Flow	1.49	-21.29	-11.17	-16.65	-19.78	Upgrade
Free Cash Flow Per Share	0.04	-0.62	-0.33	-0.49	-0.58	Upgrade
Gross Margin	64.49%	65.45%	69.26%	63.17%	67.63%	Upgrade
Operating Margin	-38.11%	-52.94%	-29.78%	-72.47%	-73.91%	Upgrade
Profit Margin	-35.75%	-52.09%	-31.27%	-42.93%	-69.79%	Upgrade
Free Cash Flow Margin	2.84%	-47.83%	-23.03%	-60.07%	-70.04%	Upgrade
EBITDA	-17.89	-21.91	-13.88	-18.47	-19.07	Upgrade
EBITDA Margin	-34.17%	-49.23%	-28.61%	-66.64%	-67.55%	Upgrade
Depreciation & Amortization	0.78	0.89	0.9	0.89	0.75	Upgrade
EBIT	-18.67	-22.8	-14.78	-19.35	-19.83	Upgrade
EBIT Margin	-35.66%	-51.23%	-30.47%	-69.84%	-70.22%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).